Steam therapy aims to zap prostate cancer without major surgery

NCT ID NCT07652164

Not yet recruiting Disease control Sponsor: Francis Medical Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 4 times

Summary

This study tests a device called Vanquish that uses water vapor (steam) to destroy prostate cancer tissue in men with Grade Group 3 intermediate-risk prostate cancer. Fifty participants will receive the treatment and be followed for two years to see if the cancer is reduced and to monitor side effects. The goal is to find a less invasive option than traditional surgery or radiation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Water vapor ablation (Vanquish System)
What this could lead to: If successful, this could offer a less invasive treatment option for intermediate-risk prostate cancer, potentially reducing the need for more aggressive surgery or radiation.
What could go wrong: This is an early, small study (50 people) with no control group. The treatment may not fully eliminate the cancer, and there are risks of side effects like urinary problems or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRADE GROUP 3 INTERMEDIATE-RISK PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.